Lilly (Eli) (LLY) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Lilly (Eli) · Health Care · ref. ETF XLV · 124 calls · price $1176.1
What the company does: Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
📈 Lilly (Eli) (LLY) stock price
$1176.1+60.7% over range
Aug 28, 25low $714.59 · high $1280.34Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
94% recommend buying · 16 analysts
📊 JPI status : Lilly (Eli) has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 LLY price target & analyst consensus — price $1,176
The price target · all analysts combined (16 targets)
Highest target · 1 firm of 16$1600+36.0%
Median target · of 16 targets$1363+15.9%
Lowest target · 1 firm of 16$850-27.7%
Current price$1176.1
Where these 16 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1594%
$1232 ↔ $1600
Below
16%
$850
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Jefferies — 72% of its targets hit on this sector (380 calls tested). It aims for $1,350 (+15 %), call made on June 10, 2026, maturing on June 10, 2027 (79 d ago).
The 11 reliable analysts
$1,350+15 %
The 5 other firms
$1,400+19 %
How to read it: the 11 reliable firms are not filtered by optimism — 11 aim above the price, 0 below, hence their $1,350 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 16 ratings (last 6 months)
Strong Buy00%
Buy1594%
Hold00%
Sell16%
Strong Sell00%
Go deeper on the analysts
🎯 LLY price target all
All 15 calls, one by one, with our verdict on each firm.
→ See all 15 targets, analyst by analyst💡 The best analysts on LLY most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in LLY? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Lilly (Eli)? The JPI assistant answers using our backtest data.
💰 Lilly (Eli) dividend: yield, history & growth › open the full page
0.54%annual yield
That's ~$6.46 per share per year.
📈 Lilly (Eli) fundamentals: valuation, margins & growth › open the full page
P/E 40.0Net margin 33.5 %Revenue growth +47.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 22 %
2023
Rev +20%Profit −16%
2024
Rev +32%Profit +102%
2025
Rev +45%Profit +95%
🔎 Detailed analyses
🏛️ Which US Congress members hold Lilly (Eli) (LLY)?
10 Congress members have disclosed LLY buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Josh Gottheimer 17× · 56%Alan Lowenthal 2× · 35%Thomas Suozzi 2× · 38%Daniel Goldman 2× · 25%Gilbert Cisneros 1× · 48%Kathy Manning 1× · 43%Dan Newhouse 1× · 33%John Curtis 1× · 62%Greg Stanton 1× · 48%Jared Moskowitz 1× · 25%
✅ Historical analyst reliability on LLY
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| HSBC ↗ | 100% | +55.9% | 2 |
| SVB Leerink | 100% | +54.8% | 3 |
| UBS ↗ | 100% | +50.2% | 6 |
| Wolfe Research ↗ | 100% | +44.3% | 2 |
| Mizuho ↗ | 100% | +36.8% | 6 |
| DZ Bank | 100% | +27.4% | 2 |
| Cowen & Co. | 100% | +25.3% | 7 |
| Wells Fargo ↗ | 91% | +45.5% | 11 |
| Citigroup ↗ | 91% | +32.2% | 11 |
| Morgan Stanley ↗ | 90% | +50.1% | 41 |
See the other 18 firms
| SunTrust Robinson Humphrey | 33% | +1.2% | 3 |
| Jefferies ↗ | 47% | +2.0% | 17 |
| Bernstein ↗ | 50% | +0.0% | 2 |
| Atlantic Equities | 50% | +0.9% | 2 |
| Edward Jones | 50% | +2.5% | 2 |
| Berenberg ↗ | 50% | +15.8% | 6 |
| BMO Capital ↗ | 53% | +10.4% | 17 |
| Leerink Swann | 57% | -0.2% | 7 |
| Deutsche Bank ↗ | 57% | +13.2% | 7 |
| Goldman Sachs ↗ | 62% | +8.3% | 8 |
| B of A Securities ↗ | 62% | +13.3% | 13 |
| Credit Suisse | 64% | +25.5% | 11 |
| Cantor Fitzgerald ↗ | 66% | +27.0% | 47 |
| Argus Research ↗ | 67% | +20.3% | 9 |
| Barclays ↗ | 78% | +26.8% | 18 |
| Guggenheim ↗ | 78% | +40.4% | 9 |
| Truist Securities ↗ | 86% | +37.0% | 14 |
| JP Morgan ↗ | 88% | +38.3% | 17 |
📊 What $1,000 invested in Lilly (Eli) would be worth › open the full page
In short — $1,000 invested in Lilly (Eli) 10 years ago would be worth $16,659 today, i.e. +32%/yr on average. Best year: 2023 (+142%), worst: 2017 (-7%). Price performance, excluding dividends.
If I'd invested $1,000 in Lilly (Eli)
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,303 | +30% |
| 3 years ago | $3,854 | +285% |
| 5 years ago | $5,854 | +485% |
Return by year (Lilly (Eli))
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +14% | $1,140 (+14%) |
| 2025 | +14% | $1,303 (+30%) |
| 2024 | +22% | $1,591 (+59%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Lilly (Eli)
Loading news…
📋 All analyst calls on LLY
Filtered on — · ✕ show all
Truist Securities ↗
Aug 7, 26
▲ Buy · 🎯$1376
Price at call : $1185.71 — upside +16%
Today : $1176.1 — upside +17%
🎯 on LLY : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Wells Fargo ↗
Aug 6, 26
▲ Overweight · 🎯$1330
Price at call : $1185.71 — upside +12%
Today : $1176.1 — upside +13%
🎯 on LLY : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Cantor Fitzgerald ↗
Aug 6, 26
▲ Overweight · 🎯$1410
Price at call : $1191.94 — upside +18%
Today : $1176.1 — upside +20%
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Buy · 🎯$1600
Price at call : $1169.17 — upside +37%
Today : $1176.1 — upside +36%
🎯 on LLY : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
▲ Outperform · 🎯$1385
Price at call : $1156.63 — upside +20%
Today : $1176.1 — upside +18%
🎯 on LLY : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Buy · 🎯$1425
Price at call : $1152.54 — upside +24%
Today : $1176.1 — upside +21%
🎯 on LLY : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
Guggenheim ↗
Jul 13, 26
▲ Buy · 🎯$1273
Price at call : $1181.87 — upside +8%
Today : $1176.1 — upside +8%
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
B of A Securities ↗
Jul 10, 26
▲ Buy · 🎯$1334
Price at call : $1181.87 — upside +13%
Today : $1176.1 — upside +13%
🎯 on LLY : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jul 10, 27
matures : Jul 10, 27
See the other 116 calls, newest to oldest
Truist Securities ↗
Jul 8, 26
▲ Buy · 🎯$1370
Price at call : $1216.95 — upside +13%
Today : $1176.1 — upside +16%
🎯 on LLY : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Morgan Stanley ↗
Jul 8, 26
▲ Overweight · 🎯$1347
Price at call : $1216.95 — upside +11%
Today : $1176.1 — upside +15%
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
RBC Capital ↗
Jul 8, 26
▲ Outperform · 🎯$1500
Price at call : $1216.95 — upside +23%
Today : $1176.1 — upside +28%
🎯 on LLY : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
▲ Overweight · 🎯$1400
Price at call : $1235.56 — upside +13%
Today : $1176.1 — upside +19%
🎯 on LLY : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
Cantor Fitzgerald ↗
Jul 6, 26
▲ Overweight · 🎯$1350
Price at call : $1200.06 — upside +12%
Today : $1176.1 — upside +15%
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Leerink Partners ↗
Jun 25, 26
▲ Outperform · 🎯$1232
Price at call : $1208.12 — upside +2%
Today : $1176.1 — upside +5%
🎯 on LLY : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Jun 25, 27
matures : Jun 25, 27
▲ Buy · 🎯$1350
Price at call : $1136.37 — upside +19%
Today : $1176.1 — upside +15%
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Jun 9, 27
matures : Jun 9, 27
B of A Securities ↗
May 26, 26
▲ Buy · 🎯$1251
Price at call : $1082.92 — upside +16%
Today : $1176.1 — upside +6%
🎯 on LLY : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
▲ Overweight · 🎯$1400
Price at call : $987.05 — upside +42%
Today : $1176.1 — upside +19%
🎯 on LLY : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Guggenheim ↗
May 5, 26
▲ Buy · 🎯$1183
Price at call : $988.87 — upside +20%
Today : $1176.1 — upside +1%
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Wolfe Research ↗
May 4, 26
▲ Outperform · 🎯$1325
Price at call : $988.87 — upside +34%
Today : $1176.1 — upside +13%
🎯 on LLY : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Cantor Fitzgerald ↗
May 1, 26
▲ Overweight · 🎯$1230
Price at call : $967.93 — upside +27%
Today : $1176.1 — upside +5%
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Guggenheim ↗
Apr 22, 26
▲ Buy · 🎯$1183
Price at call : $917.65 — upside +29%
Today : $1176.1 — upside +1%
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Morgan Stanley ↗
Apr 10, 26
▲ Overweight · 🎯$1327
Price at call : $929.55 — upside +43%
Today : $1176.1 — upside +13%
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
B of A Securities ↗
Apr 2, 26
▲ Buy · 🎯$1294
Price at call : $935.58 — upside +38%
Today : $1176.1 — upside +10%
🎯 on LLY : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Apr 2, 27
matures : Apr 2, 27
Guggenheim ↗
Mar 30, 26
▲ Buy · 🎯$1163
Price at call : $919.77 — upside +26%
Today : $1176.1 — upside -1%
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Mar 30, 27
matures : Mar 30, 27
▼ Reduce · 🎯$850
Price at call : $918.05 — upside -7%
Today : $1176.1 — upside -28%
🎯 on LLY : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Mar 17, 27
matures : Mar 17, 27
RBC Capital ↗
Feb 25, 26
▲ Outperform · 🎯$1250
Price at call : $1022.02 — upside +22%
Today : $1176.1 — upside +6%
🎯 on LLY : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Overweight · 🎯$1350
Price at call : $1058.56 — upside +28%
Today : $1176.1 — upside +15%
🎯 on LLY : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Freedom Broker
Feb 10, 26
▲ Buy · 🎯$1200
Price at call : $1025 — upside +17%
Today : $1176.1 — upside +2%
🎯 on LLY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Deutsche Bank ↗
Feb 9, 26
▲ Buy · 🎯$1285
Price at call : $1044.67 — upside +23%
Today : $1176.1 — upside +9%
🎯 on LLY : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
▲ Overweight · 🎯$1300
Price at call : $1058.18 — upside +23%
Today : $1176.1 — upside +11%
🎯 on LLY : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Cantor Fitzgerald ↗
Feb 5, 26
▲ Overweight · 🎯$1205
Price at call : $1058.18 — upside +14%
Today : $1176.1 — upside +2%
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Wells Fargo ↗
Feb 5, 26
▲ Overweight · 🎯$1280
Price at call : $1020.84 — upside +25%
Today : $1176.1 — upside +9%
🎯 on LLY : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Morgan Stanley ↗
Feb 5, 26
▲ Overweight · 🎯$1313
Price at call : $1020.84 — upside +29%
Today : $1176.1 — upside +12%
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Freedom Broker
Feb 2, 26
■ Hold neutral · not a buy · 🎯$1050
Price at call : $1044.13 — gap to target +1%
Today : $1176.1 — gap to target -11%
🎯 on LLY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Guggenheim ↗
Jan 20, 26
▲ Buy · 🎯$1161
Price at call : $1041.29 — upside +11%
Today : $1176.1 — upside -1%
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
B of A Securities ↗
Dec 15, 25
▲ Buy · 🎯$1268
Price at call : $1062.19 — upside +19%
Today : $1176.1 — upside +8%
🎯 on LLY : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wells Fargo ↗
Dec 10, 25
▲ Overweight · 🎯$1200
Price at call : $1009.38 — upside +19%
Today : $1176.1 — upside +2%
🎯 on LLY : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
BMO Capital ↗
Dec 4, 25
▲ Outperform · 🎯$1200
Price at call : $1014.49 — upside +18%
Today : $1176.1 — upside +2%
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Dec 4, 26
matures : Dec 4, 26
Guggenheim ↗
Dec 3, 25
▲ Buy · 🎯$1163
Price at call : $1014.49 — upside +15%
Today : $1176.1 — upside -1%
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Dec 3, 26
matures : Dec 3, 26
Morgan Stanley ↗
Nov 24, 25
▲ Overweight · 🎯$1290
Price at call : $1109.94 — upside +16%
Today : $1176.1 — upside +10%
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
▲ Outperform · 🎯$1300
Price at call : $1109.94 — upside +17%
Today : $1176.1 — upside +11%
🎯 on LLY : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
Truist Securities ↗
Nov 19, 25
▲ Buy · 🎯$1182
Price at call : $1043.29 — upside +13%
Today : $1176.1 — upside +1%
🎯 on LLY : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
▲ Overweight · 🎯$1150
Price at call : $1049.6 — upside +10%
Today : $1176.1 — upside -2%
🎯 on LLY : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
Morgan Stanley ↗
Nov 13, 25
▲ Overweight · 🎯$1171
Price at call : $1022.87 — upside +14%
Today : $1176.1 — upside -0%
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
▲ Buy · 🎯$1500
Price at call : $1022.87 — upside +47%
Today : $1176.1 — upside +28%
🎯 on LLY : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Freedom Broker
Nov 10, 25
■ Hold neutral · not a buy · 🎯$950
Price at call : $988.62 — gap to target -4%
Today : $1176.1 — gap to target -19%
🎯 on LLY : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Leerink Partners ↗
Nov 10, 25
▲ Outperform · 🎯$1104
Price at call : $966.64 — upside +14%
Today : $1176.1 — upside -6%
🎯 on LLY : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Buy · 🎯$1080
Price at call : $966.64 — upside +12%
Today : $1176.1 — upside -8%
🎯 on LLY : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
BMO Capital ↗
Nov 6, 25
▲ Outperform · 🎯$1100
Price at call : $937.44 — upside +17%
Today : $1176.1 — upside -6%
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Cantor Fitzgerald ↗
Oct 31, 25
▲ Overweight · 🎯$985
Price at call : $896.53 — upside +10%
Today : $1176.1 — upside -16%
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
■ Hold neutral · not a buy · 🎯$830
Price at call : $760.13 — gap to target +9%
Today : $1176.1 — gap to target -29%
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
in progress (365j)
matures : Sep 17, 26
matures : Sep 17, 26
Guggenheim ↗
Aug 13, 25
▲ Buy · 🎯$875
Price at call : $660.49 — upside +32%
Today : $1176.1 — upside -26%
Expected +32% · Actual +83% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+83.0%
stock +83% · XLV +26%
matured Aug 13, 26
Cantor Fitzgerald ↗
Aug 13, 25
▲ Overweight · 🎯$825
Price at call : $660.49 — upside +25%
Today : $1176.1 — upside -30%
Expected +25% · Actual +83% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
+83.0%
stock +83% · XLV +26%
matured Aug 13, 26
Guggenheim ↗
Jul 11, 25
▲ Buy · 🎯$942
Price at call : $793.01 — upside +19%
Today : $1176.1 — upside -20%
Expected +19% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+49.0%
stock +49% · XLV +19%
matured Jul 11, 26
Morgan Stanley ↗
Jul 10, 25
▲ Overweight · 🎯$1135
Price at call : $793.01 — upside +43%
Today : $1176.1 — upside -3%
Expected +43% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+49.0%
stock +49% · XLV +19%
matured Jul 10, 26
Guggenheim ↗
Jun 20, 25
▲ Buy · 🎯$936
Price at call : $770.64 — upside +21%
Today : $1176.1 — upside -20%
Expected +21% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+43.0%
stock +43% · XLV +14%
matured Jun 20, 26
Cantor Fitzgerald ↗
Apr 22, 25
▲ Overweight · 🎯$975
Price at call : $827.54 — upside +18%
Today : $1176.1 — upside -17%
Expected +18% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
+11.3%
stock +11% · XLV +8%
matured Apr 22, 26
Guggenheim ↗
Apr 14, 25
▲ Buy · 🎯$928
Price at call : $757.18 — upside +23%
Today : $1176.1 — upside -21%
Expected +23% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+19.5%
stock +20% · XLV +7%
matured Apr 14, 26
Morgan Stanley ↗
Apr 9, 25
▲ Overweight · 🎯$1124
Price at call : $720.91 — upside +56%
Today : $1176.1 — upside -4%
Expected +56% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+30.3%
stock +30% · XLV +9%
matured Apr 9, 26
Cantor Fitzgerald ↗
Sep 16, 24
▲ Overweight · 🎯$885
Price at call : $906.18 — upside -2%
Today : $1176.1 — upside -25%
Expected -2% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-16.1%
stock -16% · XLV -12%
matured Sep 16, 25
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight · 🎯$885
Price at call : $901.25 — upside -2%
Today : $1176.1 — upside -25%
Expected -2% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-16.3%
stock -16% · XLV -12%
matured Sep 9, 25
Morgan Stanley ↗
Aug 27, 24
▲ Overweight · 🎯$1106
Price at call : $954.48 — upside +16%
Today : $1176.1 — upside -6%
Expected +16% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-23.1%
stock -23% · XLV -12%
matured Aug 27, 25
Cantor Fitzgerald ↗
Aug 19, 24
▲ Overweight · 🎯$885
Price at call : $949.97 — upside -7%
Today : $1176.1 — upside -25%
Expected -7% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-25.7%
stock -26% · XLV -11%
matured Aug 19, 25
Guggenheim ↗
Aug 16, 24
▲ Buy · 🎯$1030
Price at call : $921.81 — upside +12%
Today : $1176.1 — upside -12%
Expected +12% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-24.3%
stock -24% · XLV -12%
matured Aug 16, 25
▲ Buy · 🎯$1050
Price at call : $931.58 — upside +13%
Today : $1176.1 — upside -11%
Expected +13% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
-24.7%
stock -25% · XLV -11%
matured Aug 14, 25
BMO Capital ↗
Aug 9, 24
▲ Outperform · 🎯$1101
Price at call : $891.68 — upside +23%
Today : $1176.1 — upside -6%
Expected +23% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
-28.8%
stock -29% · XLV -13%
matured Aug 9, 25
Guggenheim ↗
Aug 5, 24
▲ Buy · 🎯$884
Price at call : $793.18 — upside +11%
Today : $1176.1 — upside -25%
Expected +11% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-5.9%
stock -6% · XLV -12%
matured Aug 5, 25
Cantor Fitzgerald ↗
Aug 5, 24
▲ Overweight · 🎯$885
Price at call : $793.18 — upside +12%
Today : $1176.1 — upside -25%
Expected +12% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-5.9%
stock -6% · XLV -12%
matured Aug 5, 25
Cantor Fitzgerald ↗
Jul 24, 24
▲ Overweight · 🎯$885
Price at call : $821.19 — upside +8%
Today : $1176.1 — upside -25%
Expected +8% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-1.0%
stock -1% · XLV -8%
matured Jul 24, 25
Cantor Fitzgerald ↗
Jul 15, 24
▲ Overweight · 🎯$885
Price at call : $950.46 — upside -7%
Today : $1176.1 — upside -25%
Expected -7% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-18.8%
stock -19% · XLV -10%
matured Jul 15, 25
▲ Buy · 🎯$1000
Price at call : $948.4 — upside +5%
Today : $1176.1 — upside -15%
Expected +5% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
-15.7%
stock -16% · XLV -9%
matured Jul 11, 25
Morgan Stanley ↗
Jul 5, 24
▲ Overweight · 🎯$1023
Price at call : $918 — upside +11%
Today : $1176.1 — upside -13%
Expected +11% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
-15.8%
stock -16% · XLV -7%
matured Jul 5, 25
BMO Capital ↗
Jul 3, 24
▲ Outperform · 🎯$1001
Price at call : $898.1 — upside +11%
Today : $1176.1 — upside -15%
Expected +11% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
-13.1%
stock -13% · XLV -5%
matured Jul 3, 25
Cantor Fitzgerald ↗
Jul 1, 24
▲ Overweight · 🎯$885
Price at call : $906.71 — upside -2%
Today : $1176.1 — upside -25%
Expected -2% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-14.1%
stock -14% · XLV -6%
matured Jul 1, 25
Cantor Fitzgerald ↗
Jun 26, 24
▲ Overweight · 🎯$885
Price at call : $909.04 — upside -3%
Today : $1176.1 — upside -25%
Expected -3% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-14.7%
stock -15% · XLV -8%
matured Jun 26, 25
Cantor Fitzgerald ↗
Jun 25, 24
▲ Overweight · 🎯$885
Price at call : $901.26 — upside -2%
Today : $1176.1 — upside -25%
Expected -2% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-11.8%
stock -12% · XLV -8%
matured Jun 25, 25
▲ Buy · 🎯$1015
Price at call : $904.61 — upside +12%
Today : $1176.1 — upside -14%
Expected +12% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-12.4%
stock -12% · XLV -9%
matured Jun 24, 25
Cantor Fitzgerald ↗
Jun 24, 24
▲ Overweight · 🎯$885
Price at call : $904.61 — upside -2%
Today : $1176.1 — upside -25%
Expected -2% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-12.4%
stock -12% · XLV -9%
matured Jun 24, 25
▲ Buy · 🎯$957
Price at call : $865 — upside +11%
Today : $1176.1 — upside -19%
Expected +11% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-10.5%
stock -11% · XLV -9%
matured Jun 7, 25
Argus Research ↗
May 14, 24
▲ Buy · 🎯$840
Price at call : $787.02 — upside +7%
Today : $1176.1 — upside -29%
Expected +7% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
-6.8%
stock -7% · XLV -11%
matured May 14, 25
BMO Capital ↗
May 1, 24
▲ Outperform · 🎯$1001
Price at call : $755.91 — upside +32%
Today : $1176.1 — upside -15%
Expected +32% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+9.0%
stock +9% · XLV -1%
matured May 1, 25
Morgan Stanley ↗
Feb 16, 24
▲ Overweight · 🎯$950
Price at call : $755.66 — upside +26%
Today : $1176.1 — upside -19%
Expected +26% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+13.4%
stock +13% · XLV -0%
matured Feb 15, 25
Morgan Stanley ↗
Feb 7, 24
▲ Overweight · 🎯$805
Price at call : $735.68 — upside +9%
Today : $1176.1 — upside -32%
Expected +9% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+19.4%
stock +19% · XLV +2%
matured Feb 6, 25
BMO Capital ↗
Feb 7, 24
▲ Outperform · 🎯$865
Price at call : $725.38 — upside +19%
Today : $1176.1 — upside -26%
Expected +19% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+20.0%
stock +20% · XLV +2%
matured Feb 6, 25
Daiwa Capital ↗
Dec 21, 23
▲ Outperform · 🎯$610
Price at call : $572 — upside +7%
Today : $1176.1 — upside -48%
Expected +7% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 100% (1 call matured) · 📊 on Health : 40% · -1.0% (5 calls)
+34.2%
stock +34% · XLV +3%
matured Dec 20, 24
Morgan Stanley ↗
Nov 3, 23
▲ Overweight · 🎯$722
Price at call : $567.81 — upside +27%
Today : $1176.1 — upside -39%
Expected +27% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+42.0%
stock +42% · XLV +15%
matured Nov 2, 24
Morgan Stanley ↗
Oct 11, 23
▲ Overweight · 🎯$673
Price at call : $610.5 — upside +10%
Today : $1176.1 — upside -43%
Expected +10% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+52.7%
stock +53% · XLV +19%
matured Oct 10, 24
Argus Research ↗
Sep 5, 23
▲ Buy · 🎯$620
Price at call : $559.95 — upside +11%
Today : $1176.1 — upside -47%
Expected +11% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+63.0%
stock +63% · XLV +18%
matured Sep 4, 24
Morgan Stanley ↗
Sep 5, 23
▲ Overweight · 🎯$640
Price at call : $559.95 — upside +14%
Today : $1176.1 — upside -46%
Expected +14% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+63.0%
stock +63% · XLV +18%
matured Sep 4, 24
BMO Capital ↗
Aug 9, 23
▲ Outperform · 🎯$633
Price at call : $521.34 — upside +21%
Today : $1176.1 — upside -46%
Expected +21% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+71.0%
stock +71% · XLV +11%
matured Aug 8, 24
Morgan Stanley ↗
Aug 9, 23
▲ Overweight · 🎯$617
Price at call : $526.23 — upside +17%
Today : $1176.1 — upside -48%
Expected +17% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+60.6%
stock +61% · XLV +11%
matured Aug 8, 24
▲ Buy · 🎯$615
Price at call : $526.23 — upside +17%
Today : $1176.1 — upside -48%
Expected +17% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+60.6%
stock +61% · XLV +11%
matured Aug 8, 24
Morgan Stanley ↗
Jul 21, 23
▲ Overweight · 🎯$560
Price at call : $462.04 — upside +21%
Today : $1176.1 — upside -52%
Expected +21% · Actual +87% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+87.4%
stock +87% · XLV +9%
matured Jul 20, 24
Morgan Stanley ↗
Jul 11, 23
▲ Overweight · 🎯$551
Price at call : $439.39 — upside +25%
Today : $1176.1 — upside -53%
Expected +25% · Actual +114% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 83% (12 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+113.9%
stock +114% · XLV +13%
matured Jul 10, 24
BMO Capital ↗
May 4, 23
▲ Outperform · 🎯$505
Price at call : $427.81 — upside +18%
Today : $1176.1 — upside -57%
Expected +18% · Actual +79% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+79.2%
stock +79% · XLV +6%
matured May 3, 24
Guggenheim ↗
Apr 11, 23
▲ Buy · 🎯$392
Price at call : $369.05 — upside +6%
Today : $1176.1 — upside -67%
Expected +6% · Actual +106% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+105.8%
stock +106% · XLV +5%
matured Apr 10, 24
Guggenheim ↗
Dec 7, 22
▲ Buy · 🎯$401
Price at call : $371.97 — upside +8%
Today : $1176.1 — upside -66%
Expected +8% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+58.1%
stock +58% · XLV -5%
matured Dec 7, 23
▲ Buy · 🎯$375
Price at call : $360.88 — upside +4%
Today : $1176.1 — upside -68%
Expected +4% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
+64.9%
stock +65% · XLV -4%
matured Nov 22, 23
BMO Capital ↗
Sep 6, 22
▲ Outperform · 🎯$396
Price at call : $306.82 — upside +29%
Today : $1176.1 — upside -66%
Expected +29% · Actual +83% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+82.5%
stock +83% · XLV +5%
matured Sep 6, 23
BMO Capital ↗
Apr 29, 22
▲ Outperform · 🎯$358
Price at call : $289.56 — upside +24%
Today : $1176.1 — upside -70%
Expected +24% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+40.2%
stock +40% · XLV +4%
matured Apr 29, 23
▲ Buy · 🎯$305
Price at call : $263.48 — upside +16%
Today : $1176.1 — upside -74%
Expected +16% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
+36.5%
stock +37% · XLV -2%
matured Dec 20, 22
BMO Capital ↗
Nov 19, 21
▲ Outperform · 🎯$311
Price at call : $260.7 — upside +19%
Today : $1176.1 — upside -74%
Expected +19% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+38.5%
stock +39% · XLV +1%
matured Nov 19, 22
▲ Buy · 🎯$270
Price at call : $233.67 — upside +16%
Today : $1176.1 — upside -77%
Expected +16% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
+40.2%
stock +40% · XLV -3%
matured Oct 11, 22
Argus Research ↗
Dec 30, 19
▲ Buy · 🎯$165
Price at call : $131.3 — upside +26%
Today : $1176.1 — upside -86%
Expected +26% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+26.9%
stock +27% · XLV +10%
matured Dec 29, 20
BMO Capital ↗
May 1, 19
▲ Outperform · 🎯$133
Price at call : $118.46 — upside +12%
Today : $1176.1 — upside -89%
Expected +12% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
+29.7%
stock +30% · XLV +9%
matured Apr 30, 20
BMO Capital ↗
Oct 5, 18
▲ Outperform · 🎯$130
Price at call : $115.02 — upside +13%
Today : $1176.1 — upside -89%
Expected +13% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
-6.3%
stock -6% · XLV -5%
matured Oct 5, 19
BMO Capital ↗
Feb 1, 18
▼ Underperform · 🎯$74
Price at call : $81.18 — upside -9%
Today : $1176.1 — upside -94%
Expected -9% · Actual +48% · Reason (≤ −15%) : ✗ No
🎯 on LLY : 67% (12 calls matureds) · 📊 on Health : 60.7% · +8.8% (239 calls)
-48.0%
stock +48% · XLV +4%
matured Feb 1, 19
Argus Research ↗
Jan 5, 18
▲ Buy
Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+33.2%
stock +33% · XLV +1%
matured Jan 5, 19
▲ Buy · 🎯$96
Price at call : $82.52 — upside +16%
Today : $1176.1 — upside -92%
Expected +16% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+28.1%
stock +28% · XLV +13%
matured Sep 15, 18
▲ Buy · 🎯$96
Price at call : $83.7 — upside +15%
Today : $1176.1 — upside -92%
Expected +15% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+7.6%
stock +8% · XLV +9%
matured Jul 17, 18
Argus Research ↗
Aug 2, 16
▲ Buy
Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
-1.0%
stock -1% · XLV +6%
matured Aug 2, 17
▲ Buy · 🎯$105
Price at call : $80.22 — upside +31%
Today : $1176.1 — upside -91%
Expected +31% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+4.3%
stock +4% · XLV +8%
matured Jul 14, 17
▲ Buy · 🎯$105
Price at call : $72.48 — upside +45%
Today : $1176.1 — upside -91%
Expected +45% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+17.3%
stock +17% · XLV +13%
matured Mar 15, 17
▲ Buy · 🎯$115
Price at call : $87.59 — upside +31%
Today : $1176.1 — upside -90%
Expected +31% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-9.6%
stock -10% · XLV +3%
matured Sep 17, 16
▲ Buy · 🎯$100
Price at call : $83.74 — upside +19%
Today : $1176.1 — upside -91%
Expected +19% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 50% (6 calls matureds) · 📊 on Health : 42.1% · +3.1% (19 calls)
-6.6%
stock -7% · XLV +1%
matured Aug 26, 16
▲ Buy · 🎯$110
Price at call : $83.51 — upside +32%
Today : $1176.1 — upside -91%
Expected +32% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-2.3%
stock -2% · XLV -2%
matured Aug 6, 16
▲ Buy · 🎯$105
Price at call : $88.76 — upside +18%
Today : $1176.1 — upside -91%
Expected +18% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
-10.6%
stock -11% · XLV -4%
matured Jul 12, 16
Argus Research ↗
Jun 18, 15
▲ Buy
Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
-11.1%
stock -11% · XLV -8%
matured Jun 17, 16
▲ Buy · 🎯$87
Price at call : $71.88 — upside +21%
Today : $1176.1 — upside -93%
Expected +21% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+1.6%
stock +2% · XLV -7%
matured Feb 20, 16
▲ Buy · 🎯$80
Price at call : $70.87 — upside +13%
Today : $1176.1 — upside -93%
Expected +13% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on LLY : 58% (12 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+14.6%
stock +15% · XLV -4%
matured Jan 8, 16
Argus Research ↗
Oct 27, 14
▲ Buy
Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+22.2%
stock +22% · XLV +9%
matured Oct 27, 15
Guggenheim ↗
Oct 2, 14
▲ Buy · 🎯$80
Price at call : $64.83 — upside +23%
Today : $1176.1 — upside -93%
Expected +23% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 78% (9 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+35.0%
stock +35% · XLV +8%
matured Oct 2, 15
Argus Research ↗
Jul 30, 14
▲ Buy
Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+35.0%
stock +35% · XLV +22%
matured Jul 30, 15
Argus Research ↗
Apr 30, 14
▲ Buy
Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on LLY : 67% (9 calls matureds) · 📊 on Health : 55.7% · +2.6% (158 calls)
+21.6%
stock +22% · XLV +23%
matured Apr 30, 15
Frequently asked questions
Should I buy Lilly (Eli) stock?
This isn't buy advice. For Lilly (Eli), the analyst consensus is "Buy", with an average price target of $1,363 (+16% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Lilly (Eli)). We show the numbers — you decide.
Is it too late to buy Lilly (Eli)? How high can it go?
The most bullish analyst target on Lilly (Eli) is $1,600 (+36% above today's price); the average is $1,363. That's the upside they see. Check how reliable those analysts have actually been on Lilly (Eli) on our site before trusting it.
Is Lilly (Eli) still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 28 analysts have a real record on Lilly (Eli), the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Lilly (Eli)? The case for and against
The arguments for and against, one by one, from the numbers: why invest in LLY (and why hesitate).
What has Lilly (Eli)'s past performance been?
Historical returns and a "how much if I had invested" calculator: LLY performance & returns.
Does Lilly (Eli) pay a dividend?
Yield, consistency and growth history of the dividend: LLY's dividend.
What is the best month to buy LLY?
The 12 months ranked by the stock's past returns: best & worst month to buy LLY.
Are insiders buying LLY stock?
Executives' and large holders' buys and sells, decoded: insider buying on LLY.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX